Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Glioma × Interleukin-2 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 22 Neoplasm Metastasis 8 Carcinoma, Renal Cell 7 Ovarian Neoplasms 6 Lymphoma, Non-Hodgkin 6 Leukemia, Myeloid, Acute 6 Carcinoma, Non-Small-Cell Lung 6 Colorectal Neoplasms 5 Breast Neoplasms 5 Uterine Cervical Neoplasms 4 Triple Negative Breast Neoplasms 4 Stomach Neoplasms 4 Neuroblastoma 4 Neoplasms 4 Lymphoma 4 Prostatic Neoplasms 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Esophageal Neoplasms 3 Urinary Bladder Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pancreatic Neoplasms 2 Multiple Myeloma 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2 Lung Neoplasms 2 Leukemia 2 Kidney Neoplasms 2 Glioblastoma 2

Interventions

Temozolomide 24 Radiotherapy 10 Bevacizumab 10 Carboplatin 6 pembrolizumab 4 Radiation 4 Nivolumab 4 Irinotecan 4 IL13-PE38 4 Surgical Procedures, Operative 3 Erlotinib Hydrochloride 3 Aminolevulinic Acid 3 trametinib 2 temsirolimus 2 fludarabine 2 dabrafenib 2 abemaciclib 2 Vorinostat 2 Radiotherapy, Intensity-Modulated 2 Radiosurgery 2 Magnetic Resonance Spectroscopy 2 Immunotherapy, Adoptive 2 Imatinib Mesylate 2 Cyclophosphamide 2 Chlorotoxin 2 Cetuximab 2 Cancer Vaccines 2 Biopsy 2 vocimagene amiretrorepvec 1 veliparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06640582 2024-11-05

BAH2472

Essen Biotech

Phase 1/2 Recruiting

Brain Neoplasms, Glioblastoma, Glioma, Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡